Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Published in: Journal of Gastroenterology 1/2016

01-01-2016 | Letter to the Editor

Controversy regarding gastric cancer and diabetes

Authors: Midori Fujishiro, Hisamitsu Ishihara

Published in: Journal of Gastroenterology | Issue 1/2016

Login to get access

Excerpt

We have read, with great interest as diabetes specialists, the paper entitled “Gastric atrophy and xanthelasma are markers for predicting the development of early gastric cancer” [1]. The authors have found that patients who have gastric xanthelasma accompanied with diabetes have a higher risk of developing gastric cancer. …
Literature
1.
Sekikawa A, Fukui H, et al. Gastric atrophy and xanthelasma are markers for predicting the development of early gastric cancer. J Gastroenterol. 2015. doi:10.​1007/​s00535-015-1081-0.
2.
Inoue M, Iwasaki M, et al. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med. 2006;166(17):1871–7.PubMedCrossRef
3.
Khan M, Mori M, et al. Japan Collaborative Cohort Study Group. site-specific cancer risk due to diabetes mellitus history: evidence from the Japan Collaborative Cohort (JACC) Study. Asian Pac J Cancer Prev. 2006;7(2):253–9.PubMed
4.
Hidaka A, Sasazuki S, JPHC Study Group, et al. Plasma insulin, C-peptide and blood glucose and the risk of gastric cancer: the Japan Public Health Center-based prospective study. Int J Cancer. 2015;136(6):1402–10.PubMedCrossRef
5.
Kasuga M, Ueki K, et al. Report of the Japan Diabetes Society/Japanese Cancer Association joint committee on diabetes and cancer. Cancer Sci. 2013;104(7):965–76.PubMedCrossRef
Metadata
Title
Controversy regarding gastric cancer and diabetes
Authors
Midori Fujishiro
Hisamitsu Ishihara
Publication date
01-01-2016
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 1/2016
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-015-1113-9

Other articles of this Issue 1/2016

Journal of Gastroenterology 1/2016 Go to the issue

Original Article—Liver, Pancreas, and Biliary Tract

The clinical features of patients with a Y93H variant of hepatitis C virus detected by a PCR invader assay

Original Article—Alimentary Tract

NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers

ORIGINAL ARTICLE—ALIMENTARY TRACT

NUDT15 R139C-related thiopurine leukocytopenia is mediated by 6-thioguanine nucleotide-independent mechanism in Japanese patients with inflammatory bowel disease

Review

Role of epithelial cells in the pathogenesis and treatment of inflammatory bowel disease

Original Article—Liver, Pancreas, and Biliary Tract

Comparison of gadoxetic acid-enhanced magnetic resonance imaging and contrast-enhanced computed tomography with histopathological examinations for the identification of hepatocellular carcinoma: a multicenter phase III study

Original Article—Liver, Pancreas, and Biliary Tract

Pancrelipase with branched-chain amino acids for preventing nonalcoholic fatty liver disease after pancreaticoduodenectomy
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits